Skip to main content

Table 1 Characteristics of patients diagnosed with Dieulafoy’s lesion

From: Clinical characteristics of Dieulafoy’s lesion in the small bowel diagnosed and treated by double-balloon endoscopy

 

n=38

Age, years (median range)

72 (50–92)

Sex male/female

19/19

Underlying disease, n (duplicated)

 

Ischemic heart disease

9

Diabetes mellitus

9

Valvular disease

7

Arrhythmia

7

Chronic kidney disease

7

Liver cirrhosis

6

Heart failure

4

Cerebrovascular disease

2

Comorbidity Index (Ohmiya index)

 

0 and 1

12

2 and 3

20

4 and more

6

Long-term use of drugs

 

Anti-thrombus *

22

NSAIDs

4

Number of events before the first DBE

 

1

22

2

11

≥ 3

5

Time from onset to DBE, days (median range)

15 (2–68)

Lowest Blood hemoglobin level (g/dl), mean ± SD

5.9 ± 1.6

Blood transfusion, units (median range)

10 (0–36)

Prior capsule endoscopy (n)

26

Number of DBEs until confirmed diagnosis

 

1

23

2

13

3

1

5

1

  1. DBE, double-balloon endoscopy
  2. * Antithrombotic drugs included warfarin in 11 patients, low-dose aspirin in 6 patients, Clopidogrel in 2 patients, Ticlopidine in 2 patients, and Prasugrel Hydrochloride in 1 patient. They were duplicated